“…HPA-1a alloantibodies are responsible for various syndromes in immune-mediated thrombocytopenia. Although a wide range of assays and techniques have been established (Stafford et al, 2008;von dem Borne et al, 1978;Campbell et al, 2007;Meyer et al, 2006a,b;Bakchoul et al, 2007;Fujiwara et al, 2009;Wautier, 2000;Thibaut et al, 2012;Chong et al, 2011;Quiel et al, 2012), the MAIPA is still considered the gold standard for the detection of HPA-1a alloantibodies. However, the sensitivity of many of these assays has been questioned , and interlaboratory variation has been observed in the detection of HPA-specific alloantibodies Sachs et al, 2012).…”